Last Posted: Jun 23, 2022
- Rapid genomic profiling of circulating tumor DNA in non-small cell lung cancer using Oncomine Precision Assay with Genexus™ integrated sequencer.
Low Siew-Kee et al. Translational lung cancer research 2022 11(5) 711-721 - Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty
C Badowski et al, NPJ Precision Oncology, June 21, 2022 - Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
Tie Jeanne et al. The New England journal of medicine 2022 6 (24) 2261-2272 - Liquid Biopsy for Precision Adjuvant Chemotherapy in Colon Cancer.
Montagut Clara et al. The New England journal of medicine 2022 6 (24) 2330-2331 - Real-World Data on Liquid Biopsy Use in Non-Small Cell Lung Cancer in the Community Setting.
Dvir Kathrin et al. Journal of immunotherapy and precision oncology 2022 4(1) 1-5 - Blood Tests That Detect Cancers Create Risks for Those Who Use Them
G Kolata, NY Times, June 10, 2022 - A turning point in cancer A cluster of "un-heard of" results in multiple subtypes of advanced cancer
E Topol, Ground Truths, June 10, 2022 - Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma.
Madanat-Harjuoja Laura M et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 OF1-OF8 - Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience.
Caputo Vincenza et al. Therapeutic advances in medical oncology 2022 1417588359221096878 - Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panel.
Ryan Daniel J et al. Lung cancer (Amsterdam, Netherlands) 2022 16867-73
More
Search Result Summary
- CDC Information (0)
- NIH Information (7)
- CDC Publications (0)
- COVID-19 (4)
- Human Genome Epidemiologic Studies (137)
- GWAS Studies (0)
- Human Genomics Translation/Implementation Studies (123)
- Genomic Tests Evidence Synthesis (3)
- Genomic Tests Guidelines (9)
- Tier-Classified Guidelines (2)
- Non-Genomics Precision Health (2)
- Pathogen Advanced Molecular Detection (2)
- State Public Health Genomics Programs (0)
- Ethical/Legal and Social Issues (ELSI) (0)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2021
- Page last updated:Jul 03, 2022
- Content source: